AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.…
7 May 2024
AstraZeneca completes equity investment agreement with Cellectis
AstraZeneca today announced the successful completion of an equity investment with Cellectis,…
AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.…
…
ANGLE plc, the AIM-listed liquid biopsy company, has inked a major supplier agreement with pharmaceutical giant AstraZeneca. The £550,000 deal…
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to…
Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), QUALCOMM Incorporated (QCOM) and FedEx…
02 May 2024
Calquence combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO…
1 May 2024 15:00 BST
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.…
FTSE 100 continues record run boosted by Anglo American, AstraZeneca…
29 April 2024
Truqap plusFaslodex recommended for approval in the EU by CHMP for
patients with advanced ER-positive breast cancer
Recommendation based on CAPItello-291 results…
29 April 2024
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one…
…
…
Markets Defused aims to present an easy-to-understand and straightforward recap of the week’s most engaging stock market news BHP takeover approach…
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.…
The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly…
AZN earnings call for the period ending March 31, 2024.…
…
1. FTSE 100 closes at fresh record high FTSE 100 closed at a new record high of 8,078.86 after it…
Mining giant BHP approaches rival Anglo American with a takeover offer in a move that could spark the biggest shakeup…
Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär":
Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt die Aktie von AstraZeneca plc (ISIN: GB0009895292,…
Ein massiver Rückgang des Geschäfts mit Corona-Impfstoffen hatte bei vielen Pharmaaktien in der Vergangenheit zu Kursrückgängen geführt, so auch bei…
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Astrazeneca nach Quartalszahlen auf "Hold" mit einem Kursziel von 11000 Pence…
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma - Pipeline Insight, 2024" report has been added…
AstraZeneca meldete trotz Rückgangs bei Corona-Medikamenten starke Q1-Ergebnisse.…
AstraZeneca shares jump on much stronger Q1 top and bottom line…
7.09am: FTSE 100 seen flat in pre market Futures contracts have the footsie opening a couple of points lower at…
8.10am: Anglo receives ‘unsolicited’ cash offer from BHP Anglo American PLC (LSE:AAL) has confirmed a shock bid approach from BHP…
FTSE 100 up 51 points to 8,092 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays rise 9.30am: Sainsbury’s non-food exposure…
FTSE 100 up 53 points to 8,093 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays rise 11.45am AstraZeneca strips…
FTSE 100 up 32 points to 8,072 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays lead risers 8.28am: Stocks…
AstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by resilient demand for its oncology and rare…
AstraZeneca beats first-quarter revenue, profit estimates…
AstraZeneca
25 April 2024
Q1 2024 results
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Revenue and…
© Foto: Rolf Vennenbernd/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten…
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease…
AstraZenecas CEOs pay has been the subject of much debate recently. See if Pascal Soriot is justifying his £18.7 million…
The Magnificent 7 will be hogging US financial news headlines over the coming weeks. Not to be confused with the…
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) shares jumped 30% following the announcement of a strategic partnership with AstraZeneca PLC (LSE:AZN) that aims to advance...…
…
…
…
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with AstraZeneca PLC (LSE:AZN) to enhance cancer drug...…
Sales of AstraZenecas (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new…
Wenig Kursbewegung aktuell bei dem Anteilsschein von AstraZeneca plc . Die Aktie notiert derzeit bei 68,39 US-Dollar. Kaum auffällig ist…
AstraZeneca (LON:AZN) has had a great run on the share market with its stock up by a significant 7.5% over…
It was framed as a pitched battle between two opposing camps in AstraZeneca PLC (LSE:AZN)’s shareholder base. On one side,…
And AstraZeneca chief’s pay rise approved despite shareholder revolt.…